Drugs Ther Perspect (2017) 33:448 DOI 10.1007/s40267-017-0432-8 ERRATUM Erratum to: Buprenorphine oral lyophilisate (Espranor ) in the substitution treatment of opioid dependence: a proﬁle of its use Katherine A. Lyseng-Williamson Published online: 27 July 2017 Springer International Publishing AG 2017 Erratum to: Drugs Ther Perspect (2017) 33(6):241–248 DOI 10.1007/s40267-017-0408-8 Page 243, Table 1, line 10, which previously read: ‘‘Immediately after opening the blister, place on under the tongue until dispersed (usually within 15 s)’’ Should read: ‘‘Immediately after opening the blister, placed on the ton- gue until dispersed (usually within 15 s)’’ The online version of the original article can be found under doi:10.1007/s40267-017-0408-8. & Katherine A. Lyseng-Williamson email@example.com Springer, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand
Drugs & Therapy Perspectives – Springer Journals
Published: Jul 27, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera